Choline chloride; Exemption from the Requirement of a Tolerance, 760-763 [E9-31280]
Download as PDF
760
Federal Register / Vol. 75, No. 3 / Wednesday, January 6, 2010 / Rules and Regulations
number: (703) 603–0851; e-mail address:
sunderland.deirdre@epa.gov.
SUPPLEMENTARY INFORMATION:
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
I. General Information
[EPA–HQ–OPP–2008–0671; FRL–8802–4]
A. Does this Action Apply to Me?
Choline chloride; Exemption from the
Requirement of a Tolerance
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Final rule.
SUMMARY: This regulation establishes an
exemption from the requirement of a
tolerance for residues of choline
chloride (CAS Reg. No. 67–48–1)
applied pre-harvest on all raw
agricultural commodities when applied/
used as a solvent. Loveland Products,
Inc., submitted a petition to EPA under
the Federal Food, Drug, and Cosmetic
Act (FFDCA), requesting an exemption
from the requirement of a tolerance.
This regulation eliminates the need to
establish a maximum permissible level
for residues of choline chloride.
DATES: This regulation is effective
January 6, 2010. Objections and requests
for hearings must be received on or
before March 8, 2010, and must be filed
in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2008–0671. All documents in the
docket are listed in the docket index
available at https://www.regulations.gov.
Although listed in the index, some
information is not publicly available,
e.g., Confidential Business Information
(CBI) or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The
Docket Facility is open from 8:30 a.m.
to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket
Facility telephone number is (703) 305–
5805.
FOR FURTHER INFORMATION CONTACT:
Deirdre Sunderland, Registration
Division (7505P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460–0001; telephone
cprice-sewell on DSK2BSOYB1PROD with RULES
ADDRESSES:
VerDate Nov<24>2008
14:05 Jan 05, 2010
Jkt 220001
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. Potentially
affected entities may include, but are
not limited to:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
This listing is not intended to be
exhaustive, but rather provides a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Access Electronic Copies
of this Document?
In addition to accessing electronically
available documents at https://
www.regulations.gov, you may access
this Federal Register document
electronically through the EPA Internet
under the ‘‘Federal Register’’ listings at
https://www.epa.gov/fedrgstr. You may
also access a frequently updated
electronic version of 40 CFR part 180
through the Government Printing
Office’s e-CFR cite at https://
www.gpoaccess.gov/ecfr.
C. Can I File an Objection or Hearing
Request?
Under section 408(g) of FFDCA, 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. The EPA procedural
regulations which govern the
submission of objections and requests
for hearings appear in 40 CFR part 178.
You must file your objection or request
a hearing on this regulation in
accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2008–0671 in the subject line on
the first page of your submission. All
PO 00000
Frm 00022
Fmt 4700
Sfmt 4700
requests must be in writing, and must be
mailed or delivered to the Hearing Clerk
on or before March 8, 2010.
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing that does not
contain any CBI for inclusion in the
public docket that is described in
ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2
may be disclosed publicly by EPA
without prior notice. Submit your
copies, identified by docket ID number
EPA–HQ–OPP–2008–0671, by one of
the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Office of Pesticide Programs
(OPP) Regulatory Public Docket (7502P),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. Deliveries
are only accepted during the Docket
Facility’s normal hours of operation
(8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays).
Special arrangements should be made
for deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
II. Background and Statutory Findings
In the Federal Register of December 3,
2008 (73 FR 73648) (FRL–8391–3), EPA
issued a notice pursuant to section 408
of FFDCA, 21 U.S.C. 346a, as amended
by FQPA (Public Law 104–170),
announcing the filing of a pesticide
petition (PP 8E7387 ) by Loveland
Products, Inc., P.O. Box 1286, Greeley,
CO 80632–1286. The petition requested
that 40 CFR 180.920 be amended by
establishing an exemption from the
requirement of a tolerance for residues
of choline chloride when used as an
inert ingredient in pesticide
formulations applied pre-harvest. That
notice included a summary of the
petition prepared by the petitioner.
There were no comments received in
response to the notice of filing.
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish an exemption
from the requirement for a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
E:\FR\FM\06JAR1.SGM
06JAR1
Federal Register / Vol. 75, No. 3 / Wednesday, January 6, 2010 / Rules and Regulations
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue....’’
EPA performs a number of analyses to
determine the risks from aggregate
exposure to pesticide residues. First,
EPA determines the toxicity of
pesticides. Second, EPA examines
exposure to the pesticide through food,
drinking water, and through other
exposures that occur as a result of
pesticide use in residential settings.
cprice-sewell on DSK2BSOYB1PROD with RULES
III. Inert Ingredient Definition
Inert ingredients are all ingredients
that are not active ingredients as defined
in 40 CFR 153.125 and include, but are
not limited to, the following types of
ingredients (except when they have a
pesticidal efficacy of their own):
Solvents such as alcohols and
hydrocarbons; surfactants such as
polyoxyethylene ploymers and fatty
acids; carriers such as clay and
diatomaceous earth; thickeners such as
carrageenan and modified cellulose;
wetting, spreading, and dispersing
agents; propellants in aerosol
dispensers; microencapsulating agents;
and emulsifiers. The term ‘‘inert’’ is not
intended to imply nontoxicity; the
ingredient may or may not be
chemically active. Generally, EPA has
exempted inert ingredients from the
requirement of a tolerance based on the
low toxicity of the individual inert
ingredients.
IV. Toxicological Profile
Consistent with section 408(b)(2)(D)
of FFDCA, EPA has reviewed the
available scientific data and other
relevant information in support of this
action and considered its validity,
completeness and reliability and the
relationship of this information to
human risk. EPA has also considered
available information concerning the
variability of the sensitivities of major
identifiable subgroups of consumers,
including infants and children. The
nature of the toxic effects caused by
choline chloride are discussed in this
unit. The following provides a brief
summary of the risk assessment and
conclusions from the Agency’s review of
choline chloride. The Agency’s full
VerDate Nov<24>2008
14:05 Jan 05, 2010
Jkt 220001
decision document for this action is
available in the Agency’s electronic
docket (regulations.gov) under the
docket number EPA–HQ–OPP–2008–
0671.
Choline chloride is a quaternary
ammonium salt which dissociates in
water resulting in a positively charged
quaternary hydroxyl alkylammonium
ion and a negatively charged chloride
ion. Choline is an essential component
of the human diet and acts as a
precursor to acetylcholine,
phospholipids, and the methyl donor
betaine. It is important for the structural
integrity of cell membranes, cholinergic
neurotransmission, transmembrane
signaling, methyl metabolism, and lipid
and cholesterol transport and
metabolism.
Choline was officially made an
‘‘essential nutrient’’ in 1998 and
adequate intake (AI) levels were
established (women-425 milligram/day
(mg/day), pregnant women-450 mg/day,
men and lactating women-550 mg/day).
The Daily Upper Intake Level for
choline is 3.5 grams for adults. Research
indicates that many individuals are not
getting enough choline, with daily
intake levels far below the AI.
Chloride is a binary compound of
chlorine; a salt of hydrochloric acid.
Chloride is the major extracellular anion
and contributes to many body functions
including the maintenance of osmotic
pressure, acid-base balance, muscular
activity, and the movement of water
between fluid compartments. The World
Health Organization has performed two
assessments which determined that
from a toxicological point of view, there
were no concerns for the chloride ion.
It was considered to be naturallyoccurring and a normal participant of
animal and human metabolism.
Choline chloride has demonstrated a
low acute oral toxicity with LD50 values
for rats ranging from 3,150 to ≥ 6,000
milligram/kilogram (mg/kg) and LD50 for
mice in the range of 3,900 to 6,000 mg/
kg. Although appropriate animal studies
are lacking for acute dermal toxicity, an
in vitro percutaneous absorption study
performed under occluded and
unoccluded conditions showed that
choline chloride is expected to have a
low potential for percutaneous
absorption. Acceptable acute inhalation
studies are not available. Studies
conducted in the early 1960’s showed
only slight transient irritation of the
skin and eye.
Repeat dose animal studies on choline
chloride are limited. One study in mice
evaluated the impact of 200 mg/kg/day
choline chloride given orally or
intranasally for 28 days. No adverse
effects were observed with regards to
PO 00000
Frm 00023
Fmt 4700
Sfmt 4700
761
body weight, food and water
consumption, hematology, clinical
biochemistry, or histopathology of
various organs (lung, heart, liver,
spleen, and kidney). Results from
intranasal exposure to choline chloride
were comparable with their respective
controls and to other treatment groups.
The no adverse effects are observed
(NOAEL) for oral and intranasally
administered choline chloride is ≥ 200
mg/kg/day.
A 72–week feeding study in rats
administered 500 mg/kg/day of choline
chloride and observed the animals for
30 weeks post exposure. There were no
significant difference between the
control and treated group in relation to
body weights, relative liver weight,
survival rates, and the number of
neoplastic liver nodules, hepatocellular
carcinomas, lung tumors, leukemia, or
other tumors. This study resulted in a
NOAEL of 500 mg/kg/day (the highest
dose tested).
Choline is a precursor to the vital
neurotransmitter acetylcholine. Studies
show that choline has beneficial effects
on the nervous system and memory.
Choline is necessary to promote proper
development in the fetus and infant and
prevent cognitive problems. Choline
chloride is not expected to cause
neurotoxicity and it is not a known
endocrine disruptor nor are its
metabolites related to any class of
known endocrine disruptors. Based on
the results of the in vitro and in vivo
studies the Agency concluded that
choline chloride is not expected to be
carcinogenic or mutagenic.
Since the 1930’s choline chloride has
been used as a widespread nutrient in
animal feed without adverse effects
reported on fertility or teratogenicity.
The Food and Drug Administration
(FDA) requires choline be added to nonmilk based infant formulas at a
minimum concentration of 7 mg for
every 100 kilocalories (21 CFR 107.100).
Although one study did show
developmental effects, they were only
seen at very high doses (≥4,160 mg/kg/
day) and only in the presence of
maternal toxicity. There were no
observed adverse effects for both
mothers and pups exposed to 1,250 mg/
kg/day. Based on this information the
Agency concluded that choline
chloride, when used as an inert
ingredient, will not cause reproductive
or developmental toxicity and therefore,
does not anticipate an increased risk to
infants and children.
V. Aggregate Exposures
In examining aggregate exposure,
section 408 of FFDCA directs EPA to
consider available information
E:\FR\FM\06JAR1.SGM
06JAR1
762
Federal Register / Vol. 75, No. 3 / Wednesday, January 6, 2010 / Rules and Regulations
cprice-sewell on DSK2BSOYB1PROD with RULES
concerning exposures from the pesticide
residue in food and all other nonoccupational exposures, including
drinking water from ground water or
surface water and exposure through
pesticide use in gardens, lawns, or
buildings (residential and other indoor
uses).
EPA establishes exemptions from the
requirement of a tolerance only in those
cases where it can be clearly
demonstrated that the risks from
aggregate exposure to pesticide
chemical residues under reasonably
foreseeable circumstances will pose no
appreciable risks to human health. In
order to determine the risks from
aggregate exposure to pesticide inert
ingredients, the Agency considers the
toxicity of the inert in conjunction with
possible exposure to residues of the
inert ingredient through food, drinking
water, and through other exposures that
occur as a result of pesticide use in
residential settings. If EPA is able to
determine that a finite tolerance is not
necessary to ensure that there is a
reasonable certainty that no harm will
result from aggregate exposure to the
inert ingredient, an exemption from the
requirement of a tolerance may be
established.
Exposure from the use of choline
chloride is expected through the oral
route via food and drinking water.
Exposure via the dermal route may
occur for those individuals applying the
product both occupationally and
residentially. Due to the rapid
degradation of the chemical and the
natural presence of choline and chloride
in the environment, exposure from the
use of choline chloride as an inert
ingredient in pesticide products is not
expected to increase the aggregate
exposure to all subpopulation including
infants and children and therefore a
quantitative exposure assessment has
not been performed.
VI. Cumulative Effects
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
Unlike other pesticides for which EPA
has followed a cumulative risk approach
based on a common mechanism of
toxicity, EPA has not made a common
mechanism of toxicity finding as to
choline chloride and any other
substances, and these chemicals do not
appear to produce a toxic metabolite
produced by other substances. For the
VerDate Nov<24>2008
17:31 Jan 05, 2010
Jkt 220001
purposes of this tolerance action,
therefore, EPA has not assumed that
these chemicals have a common
mechanism of toxicity with other
substances. For information regarding
EPA’s efforts to determine which
chemicals have a common mechanism
of toxicity and to evaluate the
cumulative effects of such chemicals,
see the policy statements released by
EPA’s Office of Pesticide Programs
concerning common mechanism
determinations and procedures for
cumulating effects from substances
found to have a common mechanism on
EPA’s website at https://www.epa.gov/
pesticides/cumulative/.
VII. Additional Safety Factor for the
Protection of Infants and Children.
Section 408 of FFDCA provides that
EPA shall apply an additional tenfold
margin of safety for infants and children
in the case of threshold effects to
account for prenatal and postnatal
toxicity and the completeness of the
database on toxicity and exposure
unless EPA determines that a different
margin of safety will be safe for infants
and children. EPA concluded that the
FQPA safety factor for choline chloride
should be reduced to 1X.
The database for choline chloride is
adequate to make a determination of
safety for infants and children. Choline
is a natural component of a variety of
commonly consumed foods. It has been
added as a supplement to infant formula
in the United States for decades. In
addition to dietary consumption of
choline and chloride, choline is made
endogenously in the human body.
Choline is a precursor to the vital
neurotransmitter acetylcholine. Studies
show that choline has beneficial effects
on the nervous system and memory.
Choline is necessary to promote proper
development in the fetus and infant and
prevent cognitive problems. Choline
chloride is not expected to cause
neurotoxicity.
Chloride is also important for many
biological functions. It helps to maintain
the fluid balance of cells, proper blood
volume, blood pressure, and the pH of
body fluids. The World Health
Organization has performed two
assessments which determined that
from a toxicological point of view, there
were no concerns for the chloride ion.
It was considered to be naturallyoccurring and a normal participant of
animal and human metabolism.
Choline chloride has been used as a
widespread nutrient in animal feed
since the 1930’s without adverse effects
reported on fertility or teratogenicity.
Although one study in mice did show
developmental effects, they were only
PO 00000
Frm 00024
Fmt 4700
Sfmt 4700
seen at very high doses (≥4,160 mg/kg/
day) and only in the presence of
maternal toxicity. There were no
observed adverse effects for both
mothers and pups exposed to 1,250 mg/
kg/day.
Exposure to choline chloride is not
expected to significantly increase the
pre-existing levels found in commonly
eaten foods. Due to the negligible
anticipated crop residues and
subsequent exposure, the low toxicity of
the chemical and its metabolites, the
bodies need for choline from a dietary
source, and the beneficial role choline
plays in fetal development and memory;
the safety factor has been reduced to 1
X.
VIII. Determination of Safety for U.S.
Population
In addition to its low toxicity,
exposure to choline chloride will be
limited. The expected exposure
pathway is via the oral and the dermal
routes. Humans are currently exposed to
choline and chloride on a daily basis
through commonly eaten foods (both
naturally occurring and when added as
a nutrient) and through the bodies
natural ability to synthesize the
nutrient. It is unlikely that the exposure
from choline chloride, when used as an
inert ingredient applied pre-harvest to
food commodities, will significantly
increase the natural concentration of
choline and chloride in foods. Choline
and chloride are also found naturally in
the environment. Choline chloride is
readily biodegradable and because of its
high water solubility it is expected that
most of the inert will be washed from
the plant prior to consumption. Once in
water, its preferred media, it will be
broken into a quaternary hydroxyl
alkylammonium ion and a chloride ion.
Taking into consideration all available
information on choline chloride, it has
been determined that there is a
reasonable certainty that no harm to any
population subgroup, including infants
and children, will result from aggregate
exposure to this chemical. Therefore,
the exemption from the requirement of
a tolerance for residues of choline
chloride (CAS Reg. No. 67–48–1), when
used as an inert ingredient in preharvest applications, under 40 CFR
180.920 can be considered safe under
section 408(q) of the FFDCA.
IX. Other Considerations
A. Analytical Method(s)
An analytical method is not required
for enforcement purposes since the
Agency is establishing an exemption
from the requirement of a tolerance
without any numerical limitation.
E:\FR\FM\06JAR1.SGM
06JAR1
763
Federal Register / Vol. 75, No. 3 / Wednesday, January 6, 2010 / Rules and Regulations
B. International Tolerances
The Agency is not aware of any
country requiring a tolerance for choline
chloride nor have any CODEX
Maximum Residue Levels (MRLs) been
established for any food crops at this
time.
X. Conclusions
Therefore, a tolerance exemption is
established for choline chloride (CAS
Reg. No. 67–48–1) when used as inert
ingredient in pesticide formulations
applied to growing crops only.
cprice-sewell on DSK2BSOYB1PROD with RULES
XI. Statutory and Executive Order
Reviews
This final rule establishes a tolerance
under section 408(d) of FFDCA in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled Regulatory
Planning and Review (58 FR 51735,
October 4, 1993). Because this final rule
has been exempted from review under
Executive Order 12866, this final rule is
not subject to Executive Order 13211,
entitled Actions Concerning Regulations
That Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May
22, 2001) or Executive Order 13045,
entitled Protection of Children from
Environmental Health Risks and Safety
Risks (62 FR 19885, April 23, 1997).
This final rule does not contain any
information collections subject to OMB
approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et
seq., nor does it require any special
considerations under Executive Order
12898, entitled Federal Actions to
Address Environmental Justice in
Minority Populations and Low-Income
Populations (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under section 408(d) of FFDCA, such as
the exemption in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates
growers, food processors, food handlers,
and food retailers, not States or tribes,
nor does this action alter the
relationships or distribution of power
and responsibilities established by
Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such,
the Agency has determined that this
action will not have a substantial direct
effect on States or tribal governments,
on the relationship between the national
government and the States or tribal
VerDate Nov<24>2008
14:05 Jan 05, 2010
Jkt 220001
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled Consultation and Coordination
with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply
to this final rule. In addition, this final
rule does not impose any enforceable
duty or contain any unfunded mandate
as described under Title II of the
Unfunded Mandates Reform Act of 1995
(UMRA) (Public Law 104–4).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act of 1995
(NTTAA), Public Law 104–113, section
12(d) (15 U.S.C. 272 note).
XII. Congressional Review Act
The Congressional Review Act, 5
U.S.C. 801 et seq., generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report to each House of
the Congress and to the Comptroller
General of the United States. EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of this final rule in the
Federal Register. This final rule is not
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: December 24, 2009.
Lois Rossi,
Director, Registration Division, Office of
Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
■
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. In §180.920, the table is amended
by adding alphabetically the following
inert ingredients:
■
PO 00000
Frm 00025
Fmt 4700
Sfmt 4700
§ 180.920 Inert ingredients used preharvest; exemptions from the requirement
of a tolerance.
Inert ingredients
Limits
*
*
*
*
Choline chloride (CAS
-----------Reg. No. 67–48–1)
-----*
*
*
*
Uses
*
As a solvent
*
[FR Doc. E9–31280 Filed 1–5–10; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2009–0610; FRL–8802–5]
Dibenzylidene Sorbitol; Exemption
from the Requirement of a Tolerance
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Final rule.
SUMMARY: This regulation establishes an
exemption from the requirement of a
tolerance for residues of dibenzylidene
sorbitol (CAS Reg. No. 32647–67–9)
under 40 CFR 180.920 when used as the
inert ingredient in pesticdes
formulations applied in or on growing
crops. Dow Agrosciences LLC submitted
a petition to EPA under the Federal
Food, Drug, and Cosmetic Act (FFDCA),
requesting an exemption from the
requirement of a tolerance. This
regulation eliminates the need to
establish a maximum permissible level
for residues of dibenzylidene sorbitol.
DATES: This regulation is effective
January 6, 2010. Objections and requests
for hearings must be received on or
before March 8, 2010, and must be filed
in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
ADDRESSES: EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2009–0610. All documents in the
docket are listed in the docket index
available at https://www.regulations.gov.
Although listed in the index, some
information is not publicly available,
e.g., Confidential Business Information
(CBI) or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
E:\FR\FM\06JAR1.SGM
06JAR1
Agencies
[Federal Register Volume 75, Number 3 (Wednesday, January 6, 2010)]
[Rules and Regulations]
[Pages 760-763]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-31280]
[[Page 760]]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2008-0671; FRL-8802-4]
Choline chloride; Exemption from the Requirement of a Tolerance
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes an exemption from the requirement
of a tolerance for residues of choline chloride (CAS Reg. No. 67-48-1)
applied pre-harvest on all raw agricultural commodities when applied/
used as a solvent. Loveland Products, Inc., submitted a petition to EPA
under the Federal Food, Drug, and Cosmetic Act (FFDCA), requesting an
exemption from the requirement of a tolerance. This regulation
eliminates the need to establish a maximum permissible level for
residues of choline chloride.
DATES: This regulation is effective January 6, 2010. Objections and
requests for hearings must be received on or before March 8, 2010, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2008-0671. All documents in the
docket are listed in the docket index available at https://www.regulations.gov. Although listed in the index, some information is
not publicly available, e.g., Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute. Certain
other material, such as copyrighted material, is not placed on the
Internet and will be publicly available only in hard copy form.
Publicly available docket materials are available in the electronic
docket at https://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The Docket
Facility is open from 8:30 a.m. to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket Facility telephone number is (703)
305-5805.
FOR FURTHER INFORMATION CONTACT: Deirdre Sunderland, Registration
Division (7505P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number: (703) 603-0851; e-mail address:
sunderland.deirdre@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.
B. How Can I Access Electronic Copies of this Document?
In addition to accessing electronically available documents at
https://www.regulations.gov, you may access this Federal Register
document electronically through the EPA Internet under the ``Federal
Register'' listings at https://www.epa.gov/fedrgstr. You may also access
a frequently updated electronic version of 40 CFR part 180 through the
Government Printing Office's e-CFR cite at https://www.gpoaccess.gov/ecfr.
C. Can I File an Objection or Hearing Request?
Under section 408(g) of FFDCA, 21 U.S.C. 346a, any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. The EPA procedural regulations which
govern the submission of objections and requests for hearings appear in
40 CFR part 178. You must file your objection or request a hearing on
this regulation in accordance with the instructions provided in 40 CFR
part 178. To ensure proper receipt by EPA, you must identify docket ID
number EPA-HQ-OPP-2008-0671 in the subject line on the first page of
your submission. All requests must be in writing, and must be mailed or
delivered to the Hearing Clerk on or before March 8, 2010.
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing that does not contain any CBI for inclusion in the public
docket that is described in ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA
without prior notice. Submit your copies, identified by docket ID
number EPA-HQ-OPP-2008-0671, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is (703) 305-5805.
II. Background and Statutory Findings
In the Federal Register of December 3, 2008 (73 FR 73648) (FRL-
8391-3), EPA issued a notice pursuant to section 408 of FFDCA, 21
U.S.C. 346a, as amended by FQPA (Public Law 104-170), announcing the
filing of a pesticide petition (PP 8E7387 ) by Loveland Products, Inc.,
P.O. Box 1286, Greeley, CO 80632-1286. The petition requested that 40
CFR 180.920 be amended by establishing an exemption from the
requirement of a tolerance for residues of choline chloride when used
as an inert ingredient in pesticide formulations applied pre-harvest.
That notice included a summary of the petition prepared by the
petitioner. There were no comments received in response to the notice
of filing.
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish an
exemption from the requirement for a tolerance (the legal limit for a
pesticide chemical residue in or on a food) only if EPA determines that
the tolerance is ``safe.'' Section 408(b)(2)(A)(ii) of FFDCA defines
``safe'' to mean that ``there is a reasonable certainty that no harm
will result from aggregate exposure to the pesticide chemical residue,
including
[[Page 761]]
all anticipated dietary exposures and all other exposures for which
there is reliable information.'' This includes exposure through
drinking water and in residential settings, but does not include
occupational exposure. Section 408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure of infants and children to the
pesticide chemical residue in establishing a tolerance and to ``ensure
that there is a reasonable certainty that no harm will result to
infants and children from aggregate exposure to the pesticide chemical
residue....''
EPA performs a number of analyses to determine the risks from
aggregate exposure to pesticide residues. First, EPA determines the
toxicity of pesticides. Second, EPA examines exposure to the pesticide
through food, drinking water, and through other exposures that occur as
a result of pesticide use in residential settings.
III. Inert Ingredient Definition
Inert ingredients are all ingredients that are not active
ingredients as defined in 40 CFR 153.125 and include, but are not
limited to, the following types of ingredients (except when they have a
pesticidal efficacy of their own): Solvents such as alcohols and
hydrocarbons; surfactants such as polyoxyethylene ploymers and fatty
acids; carriers such as clay and diatomaceous earth; thickeners such as
carrageenan and modified cellulose; wetting, spreading, and dispersing
agents; propellants in aerosol dispensers; microencapsulating agents;
and emulsifiers. The term ``inert'' is not intended to imply
nontoxicity; the ingredient may or may not be chemically active.
Generally, EPA has exempted inert ingredients from the requirement of a
tolerance based on the low toxicity of the individual inert
ingredients.
IV. Toxicological Profile
Consistent with section 408(b)(2)(D) of FFDCA, EPA has reviewed the
available scientific data and other relevant information in support of
this action and considered its validity, completeness and reliability
and the relationship of this information to human risk. EPA has also
considered available information concerning the variability of the
sensitivities of major identifiable subgroups of consumers, including
infants and children. The nature of the toxic effects caused by choline
chloride are discussed in this unit. The following provides a brief
summary of the risk assessment and conclusions from the Agency's review
of choline chloride. The Agency's full decision document for this
action is available in the Agency's electronic docket (regulations.gov)
under the docket number EPA-HQ-OPP-2008-0671.
Choline chloride is a quaternary ammonium salt which dissociates in
water resulting in a positively charged quaternary hydroxyl
alkylammonium ion and a negatively charged chloride ion. Choline is an
essential component of the human diet and acts as a precursor to
acetylcholine, phospholipids, and the methyl donor betaine. It is
important for the structural integrity of cell membranes, cholinergic
neurotransmission, transmembrane signaling, methyl metabolism, and
lipid and cholesterol transport and metabolism.
Choline was officially made an ``essential nutrient'' in 1998 and
adequate intake (AI) levels were established (women-425 milligram/day
(mg/day), pregnant women-450 mg/day, men and lactating women-550 mg/
day). The Daily Upper Intake Level for choline is 3.5 grams for adults.
Research indicates that many individuals are not getting enough
choline, with daily intake levels far below the AI.
Chloride is a binary compound of chlorine; a salt of hydrochloric
acid. Chloride is the major extracellular anion and contributes to many
body functions including the maintenance of osmotic pressure, acid-base
balance, muscular activity, and the movement of water between fluid
compartments. The World Health Organization has performed two
assessments which determined that from a toxicological point of view,
there were no concerns for the chloride ion. It was considered to be
naturally-occurring and a normal participant of animal and human
metabolism.
Choline chloride has demonstrated a low acute oral toxicity with
LD50 values for rats ranging from 3,150 to >= 6,000
milligram/kilogram (mg/kg) and LD50 for mice in the range of
3,900 to 6,000 mg/kg. Although appropriate animal studies are lacking
for acute dermal toxicity, an in vitro percutaneous absorption study
performed under occluded and unoccluded conditions showed that choline
chloride is expected to have a low potential for percutaneous
absorption. Acceptable acute inhalation studies are not available.
Studies conducted in the early 1960's showed only slight transient
irritation of the skin and eye.
Repeat dose animal studies on choline chloride are limited. One
study in mice evaluated the impact of 200 mg/kg/day choline chloride
given orally or intranasally for 28 days. No adverse effects were
observed with regards to body weight, food and water consumption,
hematology, clinical biochemistry, or histopathology of various organs
(lung, heart, liver, spleen, and kidney). Results from intranasal
exposure to choline chloride were comparable with their respective
controls and to other treatment groups. The no adverse effects are
observed (NOAEL) for oral and intranasally administered choline
chloride is >= 200 mg/kg/day.
A 72-week feeding study in rats administered 500 mg/kg/day of
choline chloride and observed the animals for 30 weeks post exposure.
There were no significant difference between the control and treated
group in relation to body weights, relative liver weight, survival
rates, and the number of neoplastic liver nodules, hepatocellular
carcinomas, lung tumors, leukemia, or other tumors. This study resulted
in a NOAEL of 500 mg/kg/day (the highest dose tested).
Choline is a precursor to the vital neurotransmitter acetylcholine.
Studies show that choline has beneficial effects on the nervous system
and memory. Choline is necessary to promote proper development in the
fetus and infant and prevent cognitive problems. Choline chloride is
not expected to cause neurotoxicity and it is not a known endocrine
disruptor nor are its metabolites related to any class of known
endocrine disruptors. Based on the results of the in vitro and in vivo
studies the Agency concluded that choline chloride is not expected to
be carcinogenic or mutagenic.
Since the 1930's choline chloride has been used as a widespread
nutrient in animal feed without adverse effects reported on fertility
or teratogenicity. The Food and Drug Administration (FDA) requires
choline be added to non-milk based infant formulas at a minimum
concentration of 7 mg for every 100 kilocalories (21 CFR 107.100).
Although one study did show developmental effects, they were only seen
at very high doses (>=4,160 mg/kg/day) and only in the presence of
maternal toxicity. There were no observed adverse effects for both
mothers and pups exposed to 1,250 mg/kg/day. Based on this information
the Agency concluded that choline chloride, when used as an inert
ingredient, will not cause reproductive or developmental toxicity and
therefore, does not anticipate an increased risk to infants and
children.
V. Aggregate Exposures
In examining aggregate exposure, section 408 of FFDCA directs EPA
to consider available information
[[Page 762]]
concerning exposures from the pesticide residue in food and all other
non-occupational exposures, including drinking water from ground water
or surface water and exposure through pesticide use in gardens, lawns,
or buildings (residential and other indoor uses).
EPA establishes exemptions from the requirement of a tolerance only
in those cases where it can be clearly demonstrated that the risks from
aggregate exposure to pesticide chemical residues under reasonably
foreseeable circumstances will pose no appreciable risks to human
health. In order to determine the risks from aggregate exposure to
pesticide inert ingredients, the Agency considers the toxicity of the
inert in conjunction with possible exposure to residues of the inert
ingredient through food, drinking water, and through other exposures
that occur as a result of pesticide use in residential settings. If EPA
is able to determine that a finite tolerance is not necessary to ensure
that there is a reasonable certainty that no harm will result from
aggregate exposure to the inert ingredient, an exemption from the
requirement of a tolerance may be established.
Exposure from the use of choline chloride is expected through the
oral route via food and drinking water. Exposure via the dermal route
may occur for those individuals applying the product both
occupationally and residentially. Due to the rapid degradation of the
chemical and the natural presence of choline and chloride in the
environment, exposure from the use of choline chloride as an inert
ingredient in pesticide products is not expected to increase the
aggregate exposure to all subpopulation including infants and children
and therefore a quantitative exposure assessment has not been
performed.
VI. Cumulative Effects
Section 408(b)(2)(D)(v) of FFDCA requires that, when considering
whether to establish, modify, or revoke a tolerance, the Agency
consider ``available information'' concerning the cumulative effects of
a particular pesticide's residues and ``other substances that have a
common mechanism of toxicity.''
Unlike other pesticides for which EPA has followed a cumulative
risk approach based on a common mechanism of toxicity, EPA has not made
a common mechanism of toxicity finding as to choline chloride and any
other substances, and these chemicals do not appear to produce a toxic
metabolite produced by other substances. For the purposes of this
tolerance action, therefore, EPA has not assumed that these chemicals
have a common mechanism of toxicity with other substances. For
information regarding EPA's efforts to determine which chemicals have a
common mechanism of toxicity and to evaluate the cumulative effects of
such chemicals, see the policy statements released by EPA's Office of
Pesticide Programs concerning common mechanism determinations and
procedures for cumulating effects from substances found to have a
common mechanism on EPA's website at https://www.epa.gov/pesticides/cumulative/.
VII. Additional Safety Factor for the Protection of Infants and
Children.
Section 408 of FFDCA provides that EPA shall apply an additional
tenfold margin of safety for infants and children in the case of
threshold effects to account for prenatal and postnatal toxicity and
the completeness of the database on toxicity and exposure unless EPA
determines that a different margin of safety will be safe for infants
and children. EPA concluded that the FQPA safety factor for choline
chloride should be reduced to 1X.
The database for choline chloride is adequate to make a
determination of safety for infants and children. Choline is a natural
component of a variety of commonly consumed foods. It has been added as
a supplement to infant formula in the United States for decades. In
addition to dietary consumption of choline and chloride, choline is
made endogenously in the human body. Choline is a precursor to the
vital neurotransmitter acetylcholine. Studies show that choline has
beneficial effects on the nervous system and memory. Choline is
necessary to promote proper development in the fetus and infant and
prevent cognitive problems. Choline chloride is not expected to cause
neurotoxicity.
Chloride is also important for many biological functions. It helps
to maintain the fluid balance of cells, proper blood volume, blood
pressure, and the pH of body fluids. The World Health Organization has
performed two assessments which determined that from a toxicological
point of view, there were no concerns for the chloride ion. It was
considered to be naturally-occurring and a normal participant of animal
and human metabolism.
Choline chloride has been used as a widespread nutrient in animal
feed since the 1930's without adverse effects reported on fertility or
teratogenicity. Although one study in mice did show developmental
effects, they were only seen at very high doses (>=4,160 mg/kg/day) and
only in the presence of maternal toxicity. There were no observed
adverse effects for both mothers and pups exposed to 1,250 mg/kg/day.
Exposure to choline chloride is not expected to significantly
increase the pre-existing levels found in commonly eaten foods. Due to
the negligible anticipated crop residues and subsequent exposure, the
low toxicity of the chemical and its metabolites, the bodies need for
choline from a dietary source, and the beneficial role choline plays in
fetal development and memory; the safety factor has been reduced to 1
X.
VIII. Determination of Safety for U.S. Population
In addition to its low toxicity, exposure to choline chloride will
be limited. The expected exposure pathway is via the oral and the
dermal routes. Humans are currently exposed to choline and chloride on
a daily basis through commonly eaten foods (both naturally occurring
and when added as a nutrient) and through the bodies natural ability to
synthesize the nutrient. It is unlikely that the exposure from choline
chloride, when used as an inert ingredient applied pre-harvest to food
commodities, will significantly increase the natural concentration of
choline and chloride in foods. Choline and chloride are also found
naturally in the environment. Choline chloride is readily biodegradable
and because of its high water solubility it is expected that most of
the inert will be washed from the plant prior to consumption. Once in
water, its preferred media, it will be broken into a quaternary
hydroxyl alkylammonium ion and a chloride ion.
Taking into consideration all available information on choline
chloride, it has been determined that there is a reasonable certainty
that no harm to any population subgroup, including infants and
children, will result from aggregate exposure to this chemical.
Therefore, the exemption from the requirement of a tolerance for
residues of choline chloride (CAS Reg. No. 67-48-1), when used as an
inert ingredient in pre-harvest applications, under 40 CFR 180.920 can
be considered safe under section 408(q) of the FFDCA.
IX. Other Considerations
A. Analytical Method(s)
An analytical method is not required for enforcement purposes since
the Agency is establishing an exemption from the requirement of a
tolerance without any numerical limitation.
[[Page 763]]
B. International Tolerances
The Agency is not aware of any country requiring a tolerance for
choline chloride nor have any CODEX Maximum Residue Levels (MRLs) been
established for any food crops at this time.
X. Conclusions
Therefore, a tolerance exemption is established for choline
chloride (CAS Reg. No. 67-48-1) when used as inert ingredient in
pesticide formulations applied to growing crops only.
XI. Statutory and Executive Order Reviews
This final rule establishes a tolerance under section 408(d) of
FFDCA in response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993). Because this final rule has been
exempted from review under Executive Order 12866, this final rule is
not subject to Executive Order 13211, entitled Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
Protection of Children from Environmental Health Risks and Safety Risks
(62 FR 19885, April 23, 1997). This final rule does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et seq., nor does it require any
special considerations under Executive Order 12898, entitled Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under section 408(d) of FFDCA, such as the exemption in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled Federalism (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
Consultation and Coordination with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply to this final rule. In addition,
this final rule does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act of 1995 (UMRA) (Public Law 104-4).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272
note).
XII. Congressional Review Act
The Congressional Review Act, 5 U.S.C. 801 et seq., generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report to each House of the Congress and to
the Comptroller General of the United States. EPA will submit a report
containing this rule and other required information to the U.S. Senate,
the U.S. House of Representatives, and the Comptroller General of the
United States prior to publication of this final rule in the Federal
Register. This final rule is not a ``major rule'' as defined by 5
U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: December 24, 2009.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
0
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.920, the table is amended by adding alphabetically the
following inert ingredients:
Sec. 180.920 Inert ingredients used pre-harvest; exemptions from the
requirement of a tolerance.
------------------------------------------------------------------------
Inert ingredients Limits Uses
------------------------------------------------------------------------
* * * * *
Choline chloride (CAS Reg. No. ------------------ As a solvent
67-48-1)
* * * * *
------------------------------------------------------------------------
[FR Doc. E9-31280 Filed 1-5-10; 8:45 am]
BILLING CODE 6560-50-S